ADDS BASEL 2025

ActiGraph Digital Data Summit Basel 2025

SEPTEMBER 12  |  BASEL, Switzerland

WATCH ADDS 2025 VIDEO
ADDS 2024

ActiGraph Digital Data Summit 2025

February 10-12     |     Pensacola Beach, FL

Driving Adoption of Digital Measures in Clinical Research and Development

The ActiGraph Digital Data Summit (ADDS) brings together digital health leaders from across industry and academia to share real-world insights, scientific case studies, and best practices in the use of wearable technology for clinical research. Since 2022, ADDS has earned praise for its high quality scientific program and valuable networking opportunities, making it the perfect time to bring this event to Europe and connect with the region’s top digital health experts.

We're excited to announce that ADDS Basel 2025 will take place on September 12, 2025 at the
MC3 Main Conference Convention Center in Allschwil, Switzerland.

Be sure to check back regularly for new speakers and event updates!

Why Attend ADDS Basel 2025?

ADDS Basel is your chance to learn from, network with, and develop collaborations with colleagues from a variety of disciplines, including clinicians, data scientists, clinical trialists, digital health technology specialists, and public health researchers.

Scientific Case Studies

Scientific Case Studies

Panel Discussions

Panel Discussions

Networking Forums

Networking Forums

Scientific Poster Sessions

 Poster Session

Featured Speakers

Featured Speakers

Yann Amstutz

Yann Amstutz

Associate Director, Precision Medicine and Digital Health, Global Regulatory Sciences

Bristol Myers Squibb

Jonas Dorn, PhD

Jonas Dorn, PhD

Digital Biomarker Tech Lead

Roche

Evelyn Fahrenkrug

Evelyn Fahrenkrug

Global Head of Commercial Pipeline in Oncology

Boehringer Ingelheim

Dawid Gerstel, PhD

Dawid Gerstel, PhD

Lead of Data Science Implementation

Ametris (formerly ActiGraph)

Sibel Guerler

Sibel Guerler

Digital Health Lead, Hematology and Cell Therapy

Bristol Myers Squibb

Christine Guo, PhD

Christine Guo, PhD

Chief Scientific Officer

Ametris (formerly ActiGraph)

Dzmitry Kaliukhovich

Dzmitry Kaliukhovich, PhD

Sr. Principal Data Scientist II

J&J Innovative Medicine

Mathieu Lemay, PhD

Mathieu Lemay, PhD

Signal Processing and AI Group

CSEM

Dr. Rea Lehner

Rea Lehner, PhD

Digital Biomarker Science and Technology Lead

Roche

Claire Lugrin, PhD

Claire Lugrin, PhD

Postdoctoral Researcher in Data Science

Roche

Nikolay Manyakov, PhD

Nikolay Manyakov, PhD

Senior Director, AI/Machine Learning and Digital Health

J&J Innovative Medicine

Arne Mueller, PhD

Arne Muller, PhD

Associate Director, Data Science

Novartis

Bradley Petkus

Bradley Petkus

Project Manager

CSEM

Michael Pettinati, PhD

Michael Pettinati, PhD

Senior Data Scientist

Ametris (formerly ActiGraph)

Mike Rinderknecht, PhD

Mike Rinderknecht, PhD

Digital Biomarker Disease Area Lead

Roche

Rana Zia Ur Rehman, PhD

Rana Zia Ur Rehman, PhD

Data Scientist, Data Science & Digital Health

J&J Innovative Medicine

Asun Rubio

Asun Rubio

Group Leader, Edge & Cloud Software – Digital Health

CSEM

Dimitar Stanev, PhD

Dimitar Stanev, PhD

Engineer, Movement and Data Scientist

Capgemini

Marcin Straczkiewicz

Marcin Strączkiewicz, PhD

Digital Health Technologies Consultant

Lorcan Walsh, PhD

Lorcan Walsh, PhD

Head of Digital Endpoint Capability Centre

Novartis

Jeremy Wyatt

Jeremy Wyatt

Chief Executive Officer

Ametris (formerly ActiGraph)

Dr. Hang Yuan

Hang Yuan, PhD

NDPH Early Career Research Fellow

University of Oxford

Sylvain Zorman, PhD

Sylvain Zorman, PhD

Director Digital Health Sciences

Ametris (formerly ActiGraph)

Nathan Noakes

Nathan Noakes

Sensor Solutions Director

Parexel

Dr. Jonathan Soslow

Dr. Jonathan Soslow

Associate Professor, Pediatric Cardiology Director of Clinical Research, Pediatric Cardiology Co-Director of the DMD Multispecialty Clinic

Vanderbilt University Medical Center

Scientific Poster Session

ADDS Basel 2025 Scientific Poster Session

We will host a scientific poster session during ADDS Basel  featuring original research that involves the use of wearable digital health technologies (DHTs). This is an exciting opportunity for students and researchers to share their work with the broader digital health community. Abstract submissions closed on Sunday, July 27. View the list of selected poster presentations.

ADDS Basel 2025 Agenda

The ADDS Basel 2025 scientific program will consist of four focused sessions of presentations and panel discussions. Sessions on Neurology and Oncology will highlight new research findings using DHTs to advance R&D in these fields, and Technical Validation and Regulatory Pathways sessions will explore new opportunities and lessons learned, fostering discussion on how we can accelerate adoption of DHTs in regulated trials.

8:00 – 9:00
Check-In and Breakfast
9:00 – 9:10
Welcome and Opening Remarks
Christine Guo, PhD
Christine Guo, PhD
Ametris (formerly ActiGraph)
Jeremy Wyatt
Jeremy Wyatt
Ametris (formerly ActiGraph)
9:10 AM - 10:55 AM
SESSION 1: ONCOLOGY AND SAFETY MONITORING
9:10 – 9:25
From Signals to Action: Real-Time Monitoring of Pediatric Vital Signs
Eva Brack, MD, MD-PhD
Eva Brack, MD, MD-PhD
University Childrens’ Hospital Berne
Asun Rubio
Asun Rubio
CSEM
9:25 – 9:40
Exploring Digital Vital Signs for Inflammation Monitoring during LPS Challenge
Rana Zia Ur Rehman, PhD
Rana Zia Ur Rehman, PhD
J&J Innovative Medicine
9:40 – 10:05
Optimizing Data Collection to Advance Safety in Immuno-Oncology
Michael Pettinati, PhD
Michael Pettinati, PhD
Ametris (formerly ActiGraph)
Evelyn Fahrenkrug
Evelyn Fahrenkrug
Boehringer Ingelheim
10:05 – 10:50
Panel Discussion: DHT for Safety Monitoring
Michael Pettinati, PhD
Michael Pettinati, PhD
Ametris (formerly ActiGraph)
Rea Lehner, PhD
Rea Lehner, PhD
Roche
Evelyn Fahrenkrug
Evelyn Fahrenkrug
Boehringer Ingelheim
Sibel Guerler
Sibel Guerler
Bristol Myers Squibb
10:50 – 11:55
Networking Break / Poster Session
10:55 AM - 1:30 PM
SESSION 2: TECHNICAL VALIDATION
11:55 – 12:10
From Sensors to Insights: Advanced Technologies in Vital Sign and Biomarker Monitoring
Mathieu Lemay, PhD
Mathieu Lemay, PhD
CSEM
Bradley Petkus
Bradley Petkus
CSEM
12:10 – 12:25
Walking Fragmentation as a Meaningful Real-World Digital Endpoint in Heart Failure and Chronic Obstructive Pulmonary Disease
Arne Mueller, PhD
Arne Mueller, PhD
Novartis
12:25 – 12:40
Ametris Science and Technology Updates
Dawid Gerstel, PhD
Dawid Gerstel, PhD
Ametris (formerly ActiGraph)
12:40 – 12:55
The Era of Foundation Models for Human Sensing
Dr. Hang Yuan
Hang Yuan, PhD
University of Oxford
12:55 – 13:55
Networking Lunch
1:30 PM - 3:15 PM
SESSION 3: NEUROLOGY
13:55 – 14:10
Quantifying ALS Progression: Interpretable Digital Measures of Upper Limb Function in Free-Living Settings
Marcin Straczkiewicz, PhD
Marcin Straczkiewicz, PhD
Digital Health Technologies Consultant
14:10 – 14:30
From Lab to Real World: Smartphone-Based Spatio-Temporal Gait Biomarkers in Multiple Sclerosis
Mike Rinderknecht, PhD
Mike Rinderknecht, PhD
Roche
Dimitar Stanev, PhD
Dimitar Stanev, PhD
Capgemini
14:30 – 14:45
Measuring the Progression of Chorea in Huntington’s Disease Using Passive Monitoring
Claire Lugrin, PhD
Claire Lugrin, PhD
Roche
14:45 – 15:30
Networking Break / Poster Session
3:15 PM - 5:00 PM
SESSION 4: REGULATORY PATHWAYS
15:30 – 15:45
Digital Health Technologies: Digital Endpoints, Digital Biomarkers and Clinical Outcomes Assessments
Lorcan Walsh, PhD
Lorcan Walsh, PhD
Novartis
15:45 – 16:00
Lessons Learned While Developing an Actigraphy-Derived Measure of Exercise Capacity in Pulmonary Arterial Hypertension
Dzmitry Kaliukhovich, PhD
Dzmitry Kaliukhovich, PhD
J&J Innovative Medicine
16:00 – 16:20
DHT-derived Endpoints in Clinical Trials: Path to Regulatory Decision Making
Christine Guo, PhD
Christine Guo, PhD
Ametris (formerly ActiGraph)
Sylvain Zorman, PhD
Sylvain Zorman, PhD
Ametris (formerly ActiGraph)
16:20 – 17:00
Panel Discussion: Lessons Learned and Open Discussion
Lorcan Walsh, PhD
Lorcan Walsh, PhD
Novartis
Jonas Dorn, PhD
Jonas Dorn, PhD
Roche
Nikolay Manyakov, PhD
Nikolay Manyakov, PhD
J&J Innovative Medicine
Yann Amstutz
Yann Amstutz
Bristol Myers Squibb
Sylvain Zorman, PhD
Sylvain Zorman, PhD
Ametris (formerly ActiGraph)
17:00 – 17:15
Closing Remarks
Christine Guo, PhD
Christine Guo, PhD
Ametris (formerly ActiGraph)
Jeremy Wyatt
Jeremy Wyatt
Ametris (formerly ActiGraph)

MC3 Map

MC3 Logo
MC3 - Main Campus Convention Center
Switzerland Innovation Park Basel Area
Hegenheimermattweg 167D
4123 Allschwil

VIEW MAIN CAMPUS

What Did Past Attendees Say About ADDS?

It's nice to have a conference that has a very specific focus, because we can dive much deeper into that and really get into the meat of the data. You can get into a much deeper understanding of the particular topic as well as some of the advancements in the field.

Ariel Dowling, PhD

Head of Sensing and Measurement | Takeda

It's a perfect thing when you can come to a conference, and you can meet people and immediately realize that you have things in common and can help each other; to meet other people who are really in different fields, but experiencing some of the same issues and develop potential collaborations across the board.

Johathan Soslow

Pediatric Cardiologist | Vanderbuilt University

An event like this brings talent that you normally are not exposed to, and as you see these presentations, you're shocked as to how much innovation is out there.

Peter Fernandes

CEO | Bellerophon Therapeutics

I think a lot of us do research in the technology and how we can apply it to our specific research interests or populations, but learning how to cross those boundaries between clinical populations is important.

Jennifer Schrack

Professor of Epidemiology and Medicine | Johns Hopkins Bloomberg School of Public Health

Ariel Dowling
Dr. Jonathan Soslow
Peter Fernandes
Jennifer Schrack, PhD

Thank you to our Event Partner!

CSEM